Relmada Therapeutics, Inc. (RLMD)
NASDAQ: RLMD · IEX Real-Time Price · USD
3.000
-0.040 (-1.32%)
At close: May 31, 2024, 4:00 PM
2.980
-0.020 (-0.67%)
After-hours: May 31, 2024, 5:15 PM EDT
Relmada Therapeutics Market Cap
Relmada Therapeutics has a market cap or net worth of $90.52 million as of May 31, 2024. Its market cap has decreased by -2.66% in one year.
Market Cap
90.52M
Enterprise Value
6.91M
1-Year Change
-2.66%
Ranking
Category
Stock Price
$3.00
Market Cap Chart
Since September 30, 2015, Relmada Therapeutics's market cap has increased from $56.60M to $90.52M, an increase of 59.93%. That is a compound annual growth rate of 5.56%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 31, 2024 | 90.50M | -1.31% |
May 30, 2024 | 91.70M | 3.73% |
May 29, 2024 | 88.40M | -0.67% |
May 28, 2024 | 89.00M | -3.26% |
May 24, 2024 | 92.00M | -1.92% |
May 23, 2024 | 93.80M | 0.64% |
May 22, 2024 | 93.20M | -4.70% |
May 21, 2024 | 97.80M | - |
May 20, 2024 | 97.80M | -2.98% |
May 17, 2024 | 100.80M | -4.27% |
May 16, 2024 | 105.30M | 0.29% |
May 15, 2024 | 105.00M | -4.37% |
May 14, 2024 | 109.80M | 3.10% |
May 13, 2024 | 106.50M | - |
May 10, 2024 | 106.50M | -7.15% |
May 9, 2024 | 114.70M | -0.78% |
May 8, 2024 | 115.60M | 0.26% |
May 7, 2024 | 115.30M | -0.77% |
May 6, 2024 | 116.20M | 4.68% |
May 3, 2024 | 111.00M | -1.07% |
May 2, 2024 | 112.20M | 0.81% |
May 1, 2024 | 111.30M | 1.37% |
Apr 30, 2024 | 109.80M | 3.10% |
Apr 29, 2024 | 106.50M | -7.87% |
Apr 26, 2024 | 115.60M | 3.58% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Xtant Medical Holdings | 93.89M |
Sensus Healthcare | 93.41M |
Assertio Holdings | 92.92M |
Elutia | 92.79M |
SCYNEXIS | 92.56M |
Vor Biopharma | 92.29M |
Leap Therapeutics | 91.83M |
SHL Telemedicine | 90.64M |